Show simple item record

dc.contributor.authorSumarawati, Titiek
dc.contributor.authorRiwanto, Ignatius
dc.contributor.authorHadisaputro, Soeharyo
dc.contributor.authorDharmana, Edi
dc.date.accessioned2012-12-12T04:18:45Z
dc.date.available2012-12-12T04:18:45Z
dc.date.issued2012-06
dc.identifier.citationAmerican cancer society, 2009, Cancer Fact and Figures Apantaku LM, 2002, Breast-conseving surgery for breast cancer, Am. Fam. Physician 66(12):2271-2278. Ashariati, Ami., 2007, Ekspresi Her-2/neu dan mdr-1 berkorelasi dengan gen MDR-1 pada penderita kanker payudara “locally Advanced” Pasca Pengobatan antrasiklin. ADLN Digital Collection-GDL 4.0. Unair. Surabaya. Beretta G, 1991. Cancer Treatment Medical Guide, 10 th ed Milan: Farmitalia Carlo Erba Erbamont, hal. 174-176 Cameiro-Fiho B.A, Lima I.P.F, Araujo D.H, Cavalcante M.C, Carvalho H.P, Britto G.A.C, Lima V, Monteiro S.M.N, Santos F.N, Riberto R.A, Intestinal fuction and Secretion in Methotrexate induced Rat intestinal Mucositis. Digestive Diseases And Sciences. Volume 49, number 1,65-77. Avaiable from: URL: http:/www. Springer link.com/Content/v832784x 053r21k3 Dahlan M Spiyudin, 2008, Statistik untuk kedokteran dan kesehatan. Salemba Medika, Edisi ke-3, hal 47-191. Faried A, Kurnia D, Faried LS, Usman N, T Miyazaki, Kato H, 2007, Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff) Boerl, on human cancer cell lines. Int J Oncol 30:605- Avaiable from: Goodman and Gilman, 2006, The Pharmacological Basis of Therapeutics. International edition. McGraw-Hill; P.12- 20. Hanifah, K.A, 1993, Rancangan Percobaan Teori dam Aplikasi, Rajawali Press, Jakarta. Komen Susan G, 2010, NCCN Guidelines for pasients, Breast Cancer. Available NCCN.com, p51-60 Kusumawati. Diah, 2004, Bersahabat dengan hewan coba. Gajahmada University Press. Jogjakarta. Lanari C., Lamb C.A, Fabris V.T, Helguero L.A, Soldiati R, Battino M.C, Giulianelli S, Pablo C.J, Molinolo V and Molinolo, 2009, The medroxyprogesterone acetate mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocrine Related Cancer, 16 333-350. Lazuardi M, 2010, Biofarmasetik dan Farmakokinetik klinik Medis Veteriner, Galiah Indonesia, Bogor. Lisdawati V, 2002, Buah Mahkota Dewa, Toksisitas, Efek antioksidan dan efek kanker berdasarkan Uji penapisan Farmakologi, Jurnal Medica Indonesia, 9(3): 34-39. Mae Sri Hartati W, Sofia Mubarika, Ibnu G. Gandjar, Mark T Hamann,KV. Rao & Subagus Wahyuon, 2005, Phalerin, glukosida benzonfenon baru diisolasi dari ekstrak metanolik daun Mahkota Dewa (Phaleria macrocarpa [scheff]. Boerl. Majalah Farmasi Indonesia ; 16 (1) ; 51- 57. Meiyanto E, Susilowati S, Tasminatun S, Murwanti R, Sugiyanto, 2007, Efek ekstrak etanolik Gynura procumbens (Lour.) Merr. terhadap penghambatan pertumbuhan tumor payudara tikus yang diinduksi DMBA. Majalah Farmasi Indonesia; 18(4) : p. 169-175 Nawawi A, 2004, Isolasi Benzonfenon dari daun Mahkota Dewa (Phaleria macrocarpa [scheff]. Boerl, Acta Pharmaceutika, Indonesia. Santoso G, 2007, Fundamental Metodologi Penelitian Kuantitatif dan Kualitatif. Cetakan kedua, Jakarta: Prestasi Pustaka Publisher; hal 27-44. Shargel,L, Andrew B.C, 1999, Applied Biopharmaceutic and Pharmacokinetics, 4th, Appleton Inc, USA. URL:http://209.85.175.104/search?q=cach e:wIX06p8c49wJ:www.spandisos.com /journalweb/serveFile/ijo 303605PDF.pdf.en_US
dc.identifier.isbn978-602-18711-0-2
dc.identifier.urihttp://hdl.handle.net/11617/2294
dc.description.abstractThe therapy for cancer has used the combination regiment of adriamycin and cyclophoshamide that may cause deoxyribonucleic acid damage of cancer cells and organs. One of its side effects is the disturbance of absorption in the intestinal mucosa. Phaleria macrocarpa has been reported to have anticancer activity. There has been no studies conducted on the phalerin level of Phaleria macrocarpa in portal vein. The aim of this study was to examine the concentration of phalerin in the Phaleria macrocarpa in C3H mice with adenocarsinoma mamma between treated group of Phaleria macocarpa (PH) and combination (PH, Adriamycin (ADR), and Cyclophosphamide (CYC)). The experiment was conducted using posttest only control group design, 12 female C3H with adenocarsinoma mamma were divided into 2 groups of 6 mice each to get one of the following treatment: PH (0.14 mg/day p.o) or combination (PH 0.14 mg/day p.o; followed by ADH 0.013 mg i.p. and CYC 0.0156 mg i.p.). High Performance Liquid Chromatography, detector Spectra System (Knauer, 2006), spectroscopy detector systems UV 600 LP, Lichrosorb coloumn RP.18 (250 x 4 x 5 µm) were used to assess the concentration of Phalerin. Phalerin as marker was obtained from medical herbal centre, Faculty of Medicine, Gadjah Mada University. Blood sample was taken from portal vein at 30, 60, 90 min. to asses the concentration of phalerin absorbance in time series. Data were presented in table and boxplot then analyzed with independent T-test to find out the difference between the groups with a significance level less than 0,05 (p<0.05) and Confidence Interval of 95%. Phaleria macrocarpa followed by adriamycin and cyclophosphamide in combination group reduced the absorption indicated by the significant difference in level of phalerin between treated group by time. It was concluded that the phalerin concentration in PH group have a higher value compare to combination group.en_US
dc.language.isoenen_US
dc.publisherMuhammadiyah University Pressen_US
dc.subjectconcentration of phalerinen_US
dc.subjectPhaleria macrocarpaen_US
dc.subjectAdriamycinen_US
dc.subjectCyclophoshamideen_US
dc.titleConcentration of Phalerin from Phaleria macrocarpa in Vena Porta: An Experimental Study on Adenocarcinoma Mammae in C3H Mice That Given Adriamycin and Cyclophosphamideen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record